A multicenter phase II trial of docetaxel and capecitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer-Reference-Cited by-同舟云学术

A multicenter phase II trial of docetaxel and capecitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer

Published:2012-06-06 Issue:1 Volume:70 Page:169-176
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Karachaliou N.,Ziras N.,Syrigos K.,Tryfonidis K.,Papadimitraki E.,Kontopodis E.,Bozionelou V.,Kalykaki A.,Georgoulias V.,Mavroudis D.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-012-1901-3.pdf

Reference42 articles.

1. Miles David (2008) Capecitabine and docetaxel in the treatment of metastatic breast cancer: combination, sequence or single agent? EJC Suppl 6(8):5–8

2. O’Shaughnessy J, Miles D et al (2002) Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results. J Clin Oncol 20(12):2812–2823

3. Blum JL, Jones SE et al (1999) Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer. J Clin Oncol 17:485–493

4. Blum JL, Dieras V et al (2001) Multicenter, phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma. Cancer 92:1759–1768

5. Sawada N, Ishikawa T et al (1998) Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts. Clin Cancer Res 4:1013–1019

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study of loss of the active principle capecitabine and cytotoxic activity in preparation intended for administration in liquid form;2024-03-18

2. Update on Classic and Novel Approaches in Metastatic Triple-Negative Breast Cancer Treatment: A Comprehensive Review;Biomedicines;2023-06-20

3. Randomized Phase III Trial Comparing Epirubicin/ Doxorubicin Plus Docetaxel and Epirubicin/ Doxorubicin Plus Paclitaxel as First Line Treatment in Women with Advanced Breast Cancer;Journal for Research in Applied Sciences and Biotechnology;2023-06-12

4. Non-Surgical Management of Metastatic Breast Cancer and Palliative Care;Breast Cancer;2022

5. Fever and breast cancer: A critical review of the literature and possible underlying mechanisms;Breast Disease;2021-07-15